Articles
New Directions in the Treatment of Multiple Myeloma: Reports on Carfilzomib-Based Therapy from ASH 2012
A Pharmacist’s Perspective: Carfilzomib-Based Therapies for Multiple Myeloma
A Nurse’s Perspective: Carfilzomib-Based Therapies for Multiple Myeloma
A Payer’s Perspective: How Payers May Respond to the Evolving Pharmacologic Management of Multiple Myeloma
To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".